Clinical Edge Journal Scan

Heavy secondhand smoke exposure tied to higher risk for severe headaches or migraine


 

Key clinical point: Heavy secondhand smoke (SHS) exposure was positively associated with a higher risk for severe headaches or migraine in adults who never smoked.

Major finding : Heavy SHS exposure (serum cotinine level 1 -10 ng/mL) was positively associated with severe headaches or migraine (adjusted odds ratio 2.02; P = .011). No significant association was observed between low SHS exposure (serum cotinine level 0.05-0.99 ng/mL) and headaches or migraine ( P = .226).

Study details: This nationwide cross-sectional study included 4560 adults who had never smoked, of which 20% had severe headaches or migraine.

Disclosures: This study did not receive any funding from external sources. The authors declared no conflicts of interest.

Source: Wu J, Yang P, et al. Association between secondhand smoke exposure and severe headaches or migraine in never-smoking adults. Headache. 2023 (Nov 8). doi: 10.1111/head.14640

Recommended Reading

Switching Patients From a Triptan to a Gepant for Acute Migraine Care and Effective Preventives
Migraine ICYMI
Adolescents with migraine need smooth handoff to adult care
Migraine ICYMI
Ketogenic diets improve symptoms and fatigue in chronic and high-frequency episodic migraine
Migraine ICYMI
Real-world evidence on efficacy of anti-CGRP mAbs in elderly patients with migraine
Migraine ICYMI
Anti-CGRP antibodies improve depressive symptoms in migraine
Migraine ICYMI
BMI and migraine risk in adolescents: What’s the link?
Migraine ICYMI
Effect of CGRP mAb rollout on prescription patterns of other migraine preventive therapies
Migraine ICYMI
Ubrogepant and anti-CGRP mAb combo is effective for acute treatment of migraine
Migraine ICYMI
Remote electrical neuromodulation: A pill-free, needle-free option for long-term migraine management
Migraine ICYMI
Heart rate variability may help predict treatment response in chronic migraine
Migraine ICYMI